Stereotaxis, Inc. 8-K Filing Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by Stereotaxis, Inc. on May 21, 2019. The filing details the voting results for five specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
Shareholders approved all five proposals presented at the meeting. Key outcomes include:
- Director Elections: All three nominees (Robert J. Messey, Nathan Fischel, M.D., and Ross B. Levin) were elected to the Board of Directors.
- Accounting Firm: Shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2019.
- ESPP Amendment: Approved an amendment to the Employee Stock Purchase Program to make an additional 250,000 shares available for issuance.
- Reverse Stock Split: Approved an amendment to the certificate of incorporation to authorize a reverse stock split of the common stock.
- Authorized Share Reduction: Approved a reduction of the authorized number of common shares from 300,000,000 to 100,000,000.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of voting results.
Investor Verification Checklist
- Verify the implementation timeline for the authorized reverse stock split.
- Confirm the specific ratio of the reverse stock split once determined by the Board.
- Review the updated Employee Stock Purchase Program terms regarding the additional 250,000 shares.
- Monitor future filings for the effective date of the reduction in authorized common shares.